These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16410812

  • 1. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.
    Funatsu H, Yamashita H, Mimura T, Noma H, Nakamura S, Hori S.
    Eye (Lond); 2007 Mar; 21(3):377-82. PubMed ID: 16410812
    [Abstract] [Full Text] [Related]

  • 2. Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.
    Funatsu H, Yamashita H, Noma H, Mimura T, Sakata K, Hori S.
    Br J Ophthalmol; 2004 Aug; 88(8):1064-8. PubMed ID: 15258026
    [Abstract] [Full Text] [Related]

  • 3. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H, Kishi S, Kotajima N, Murakami M.
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [Abstract] [Full Text] [Related]

  • 4. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, Murakami T, Kimura T, Takagi H.
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [Abstract] [Full Text] [Related]

  • 5. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N.
    Ophthalmic Res; 2012 Mar; 47(1):7-12. PubMed ID: 21691136
    [Abstract] [Full Text] [Related]

  • 6. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy.
    Wakabayashi Y, Usui Y, Okunuki Y, Ueda S, Kimura K, Muramatsu D, Kezuka T, Goto H.
    Invest Ophthalmol Vis Sci; 2012 Sep 21; 53(10):6403-10. PubMed ID: 22899753
    [Abstract] [Full Text] [Related]

  • 7. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H.
    Ophthalmology; 2008 Nov 21; 115(11):1916-22. PubMed ID: 18718666
    [Abstract] [Full Text] [Related]

  • 8. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V.
    Retina; 2008 Jun 21; 28(6):817-24. PubMed ID: 18536597
    [Abstract] [Full Text] [Related]

  • 9. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
    Yeh PT, Yang CM, Huang JS, Chien CT, Yang CH, Chiang YH, Shih YF.
    Ophthalmology; 2008 Apr 21; 115(4):734-737.e1. PubMed ID: 18177940
    [Abstract] [Full Text] [Related]

  • 10. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X, Wang G, Wang Y.
    Am J Ophthalmol; 2009 Dec 21; 148(6):883-9. PubMed ID: 19837381
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab.
    Ma Y, Zhang Y, Zhao T, Jiang YR.
    Am J Ophthalmol; 2012 Feb 21; 153(2):307-313.e2. PubMed ID: 21982107
    [Abstract] [Full Text] [Related]

  • 12. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S.
    Ophthalmology; 2003 Sep 21; 110(9):1690-6. PubMed ID: 13129863
    [Abstract] [Full Text] [Related]

  • 13. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
    Limb GA, Hickman-Casey J, Hollifield RD, Chignell AH.
    Invest Ophthalmol Vis Sci; 1999 Sep 21; 40(10):2453-7. PubMed ID: 10476819
    [Abstract] [Full Text] [Related]

  • 14. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
    Zheng B, Li T, Chen H, Xu X, Zheng Z.
    Am J Ophthalmol; 2011 Dec 21; 152(6):1039-43. PubMed ID: 21851923
    [Abstract] [Full Text] [Related]

  • 15. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R, Simó R, Audí L, Mateo C, Mesa J, García-Ramírez M, Carrascosa A.
    Diabetologia; 1997 Sep 21; 40(9):1107-9. PubMed ID: 9300249
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S, Nakama T, Ishikawa K, Arima M, Tachibana T, Nakao S, Sassa Y, Yasuda M, Enaida H, Oshima Y, Kono T, Ishibashi T.
    Invest Ophthalmol Vis Sci; 2012 Oct 09; 53(11):6997-7003. PubMed ID: 22977138
    [Abstract] [Full Text] [Related]

  • 19. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R, Mediero A, Martínez-Montero JC, Roldán-Pallarés M, Suárez-Leoz M, Vidal-Fernández P, Cortés-Valdés C, Fernández-Cruz A, Fernández-Durango R.
    Mol Vis; 2004 Jul 15; 10():450-7. PubMed ID: 15273657
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.